RPS6KA2(Ribosomal Protein S6 Kinase A2,核糖体蛋白S6激酶A2)属于RSK(Ribosomal S6 Kinase,核糖体S6激酶)家族,该家族是一类丝氨酸/苏氨酸蛋白激酶,主要参与调控细胞生长、增殖、存活和代谢等过程。RPS6KA2通过磷酸化下游靶蛋白(如转录因子CREB和核糖体蛋白S6)传递信号,其活性受MAPK/ERK通路(促分裂原活化蛋白激酶/细胞外信号调节激酶通路)调控。该基因在神经系统、肌肉组织和免疫系统中高表达,对突触可塑性(神经元连接强度的调节能力)和记忆形成有重要作用。突变可能导致功能异常,例如错义突变(单个氨基酸改变)可能削弱激酶活性,与智力障碍、自闭症谱系障碍等神经发育疾病相关;而某些突变可能增强激酶活性,促进肿瘤发生。RPS6KA2过表达常见于乳腺癌、前列腺癌等恶性肿瘤,通过激活促生存信号加速癌细胞增殖;低表达则可能影响神经元功能,导致认知缺陷。RSK家族共性包括:依赖ERK激活、含有两个激酶结构域(N端负责自磷酸化,C端负责底物磷酸化),并能穿梭于细胞核与细胞质传递信号。该基因与疾病关联的研究仍在深入,例如在阿尔茨海默病中可能通过tau蛋白(一种与微管结合的神经蛋白)磷酸化参与病理过程。
This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
该基因编码对RSK(核糖体S6激酶)家族丝氨酸/苏氨酸激酶的成员。这种激酶包含2不相同激酶催化结构域和磷酸化多种底物,包括信号转导通路的促分裂原活化激酶(MAPK)的成员。此蛋白的活性已牵涉在控制细胞生长和分化。备用转录剪接变体,编码不同同种型,已经表征。 [由RefSeq的,2008年7月提供]
RPS6KA2基因(以及对应的蛋白质)的细胞分布位置:
RPS6KA2基因的本体(GO)信息:
| 名称 |
|---|
| 4010 MAPK signaling pathway [PATH:hsa04010] |
| 4150 mTOR signaling pathway [PATH:hsa04150] |
| 4114 Oocyte meiosis [PATH:hsa04114] |
| 4914 Progesterone-mediated oocyte maturation [PATH:hsa04914] |
| 4720 Long-term potentiation [PATH:hsa04720] |
| 4722 Neurotrophin signaling pathway [PATH:hsa04722] |
| 名称 |
|---|
| Activated TLR4 signalling |
| Activation of NMDA receptor upon glutamate binding and postsynaptic events |
| Axon guidance |
| Cellular responses to stress |
| Cellular Senescence |
| CREB phosphorylation |
| CREB phosphorylation through the activation of Ras |
| Developmental Biology |
| ERK/MAPK targets |
| Gastrin-CREB signalling pathway via PKC and MAPK |
| Immune System |
| Innate Immune System |
| L1CAM interactions |
| MAP kinase activation in TLR cascade |
| MAPK targets/ Nuclear events mediated by MAP kinases |
| MyD88 cascade initiated on plasma membrane |
| MyD88 dependent cascade initiated on endosome |
| MyD88-independent TLR3/TLR4 cascade |
| MyD88:Mal cascade initiated on plasma membrane |
| Neuronal System |
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell |
| NGF signalling via TRKA from the plasma membrane |
| Nuclear Events (kinase and transcription factor activation) |
| Post NMDA receptor activation events |
| Recycling pathway of L1 |
| RSK activation |
| Senescence-Associated Secretory Phenotype (SASP) |
| Signaling by GPCR |
| Signalling by NGF |
| Toll Like Receptor 10 (TLR10) Cascade |
| Toll Like Receptor 2 (TLR2) Cascade |
| Toll Like Receptor 3 (TLR3) Cascade |
| Toll Like Receptor 4 (TLR4) Cascade |
| Toll Like Receptor 5 (TLR5) Cascade |
| Toll Like Receptor 7/8 (TLR7/8) Cascade |
| Toll Like Receptor 9 (TLR9) Cascade |
| Toll Like Receptor TLR1:TLR2 Cascade |
| Toll Like Receptor TLR6:TLR2 Cascade |
| Toll-Like Receptors Cascades |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
| TRAF6 Mediated Induction of proinflammatory cytokines |
| Transmission across Chemical Synapses |
| TRIF-mediated TLR3/TLR4 signaling |
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Blood pressure finding | 0.12 | 1 | 1 | GWASCAT |
| Dental caries | 0.12 | 1 | 1 | GWASCAT |
| Systemic arterial pressure | 0.12 | 1 | 1 | GWASCAT |
| Sclerosis | 0.00272435 | 1 | 0 | LHGDN |
| Mammary Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Rectal Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Colonic Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Tobacco Use Disorder | 0.002367032 | 1 | 0 | GAD |
| Prostate carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。